Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome
about
Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancerTwo different, mutually exclusively distributed, TP53 mutations in ovarian and peritoneal tumor tissues of a serous ovarian cancer patient: indicative for tumor origin?Dynamic changes of tumor gene expression during repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC) in women with peritoneal cancer.Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary diseaseOverexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancerSmall RNAs and the competing endogenous RNA network in high grade serous ovarian cancer tumor spread.Genetic variants of lncRNA HOTAIR and risk of epithelial ovarian cancer among Chinese women.Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer.Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer.Absence of PD-L1 on tumor cells is associated with reduced MHC I expression and PD-L1 expression increases in recurrent serous ovarian cancer.EV-Associated MMP9 in High-Grade Serous Ovarian Cancer Is Preferentially Localized to Annexin V-Binding EVs.VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients.Ascites-derived IL-6 and IL-10 synergistically expand CD14+HLA-DR-/low myeloid-derived suppressor cells in ovarian cancer patients.Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer
P2860
Q26746203-2B7159FE-0D58-4C2F-BED5-4D506D7335D0Q33865112-2A6BD02E-9CA4-4D27-8CEE-81E746947A81Q36108028-A9716D6F-A346-4499-8798-D2C9CF56B721Q36248459-583E9ADF-6247-4B34-AE98-1AD73B889973Q36729517-028FA27C-453A-4033-BE14-5B034D8F221CQ37457617-90089D99-E12C-4626-B78C-F8D049FF17EAQ37520145-E12047D3-B066-4778-961D-9DF1428B155DQ37641608-345936BA-A320-4931-A3DF-FAE8DF0ED565Q38791320-71F5A3D9-9ADC-4CE6-9B9C-6700B35F6DEAQ42056165-AB602471-68F2-4748-AF27-7F316AC1FB7EQ42098090-296D38D3-62BA-4947-A81A-BF5B401DCA52Q42229919-57589A15-723A-4D89-A544-1F3C9AAD93F3Q45813459-899B7284-74C6-4FCF-88A4-B7BD4A782D08Q58797242-0FC648DF-134A-400F-B3AD-B9A2F1D0D26A
P2860
Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Peritoneal tumor spread in ser ...... mesenchymal status and outcome
@ast
Peritoneal tumor spread in ser ...... mesenchymal status and outcome
@en
type
label
Peritoneal tumor spread in ser ...... mesenchymal status and outcome
@ast
Peritoneal tumor spread in ser ...... mesenchymal status and outcome
@en
prefLabel
Peritoneal tumor spread in ser ...... mesenchymal status and outcome
@ast
Peritoneal tumor spread in ser ...... mesenchymal status and outcome
@en
P2093
P2860
P50
P356
P1433
P1476
Peritoneal tumor spread in ser ...... mesenchymal status and outcome
@en
P2093
Christoph Grimm
Dietmar Pils
Katharina Auer
Nyamdelger Sukhbaatar
Reinhard Horvat
Stefanie Aust
P2860
P304
17261-17275
P356
10.18632/ONCOTARGET.3746
P407
P577
2015-07-01T00:00:00Z